Calviri Company
Calviri provides cancer treatment products by combining the immunogenic source of neoantigens with a peptide array platform.
Technology:
Peptides and Proteins
Industry:
Peptides and Proteins
Headquarters:
Tempe, Arizona, United States
Founded Date:
2018-01-01
Employees Number:
1-10
Investors Number:
2
Total Funding:
11537153
Last Funding Date:
2021-11-09
Last Funding Type:
Venture - Series Unknown
Register and Claim Ownership